Search

Your search keyword '"Marteau, Jean-Brice"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Marteau, Jean-Brice" Remove constraint Author: "Marteau, Jean-Brice" Search Limiters Full Text Remove constraint Search Limiters: Full Text
20 results on '"Marteau, Jean-Brice"'

Search Results

1. Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B

Catalog

Books, media, physical & digital resources

7. Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males

9. 468. GLP-Compliant Non-Clinical Safety and Biodistribution of a Recombinant AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI

10. 464. RCL-Pooling Assay: A Simplified Method for the Detection of Replication Competent Lentiviruses in Vector Batches Using Sequential Pooling

11. Identification of cis and trans acting genetic variants explaining up to half the variation in circulating VEGF levels

13. Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels

14. Identification of cis - and trans -Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels

15. Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELBin an aggressive subset of chronic lymphocytic leukemia in males

18. Concomitant heterochromatinisation and downregulationof gene expression unveils epigeneticsilencing of RELB in an aggressive subset ofchronic lymphocytic leukemia in males.

19. Parental precocious influences on offspring cardiovascular risk markers: an exploratory study in the STANISLAS Cohort.

20. Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI